Cell-based therapy approaches: the hope for incurable diseases.
暂无分享,去创建一个
Yaron Mazor | Yaron Mazor | D. Warshawsky | R. Shtrichman | Ronit Shtrichman | Ella Buzhor | Hila Barash | David Warshawsky | E. Buzhor | Lucy Leshansky | Jacob Blumenthal | H. Barash | Lucy Leshansky | Jacob Blumenthal | Hila Barash
[1] U. Schlötzer-Schrehardt,et al. Stem cell-based therapy for corneal epithelial reconstruction: present and future. , 2013, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[2] P. Taupin. HuCNS-SC (StemCells). , 2006, Current opinion in molecular therapeutics.
[3] R. S. Goldstein,et al. Reactivation of NCAM1 defines a subpopulation of human adult kidney epithelial cells with clonogenic and stem/progenitor properties. , 2013, The American journal of pathology.
[4] Timothy A. Blenkinsop,et al. Ophthalmologic stem cell transplantation therapies. , 2012, Regenerative medicine.
[5] Preeti Chhabra,et al. Stem Cell Therapy to Cure Type 1 Diabetes: From Hype to Hope , 2013, Stem cells translational medicine.
[6] George A. Williams,et al. Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration , 2011, Proceedings of the National Academy of Sciences.
[7] G. Eknoyan,et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[8] Jeffrey A. Bluestone,et al. In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.
[9] Martin Michaelis,et al. Osteoarthritis — an untreatable disease? , 2005, Nature Reviews Drug Discovery.
[10] M. Sogayar,et al. Cell‐based interventions to halt autoimmunity in type 1 diabetes mellitus , 2013, Clinical and experimental immunology.
[11] M. Nireekshan Kumar,et al. Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy , 2014, The EMBO journal.
[12] I. Wilmut,et al. Using human induced pluripotent stem cells to treat retinal disease , 2013, Progress in Retinal and Eye Research.
[13] J. Cecka. The OPTN/UNOS Renal Transplant Registry. , 2005, Clinical transplants.
[14] B. Christ,et al. Mesenchymal Stem Cell-Derived Hepatocytes for Functional Liver Replacement , 2012, Front. Immun..
[15] A. Soejitno,et al. The prospect of induced pluripotent stem cells for diabetes mellitus treatment , 2011, Therapeutic advances in endocrinology and metabolism.
[16] A. Halverson,et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. , 2005, Gastroenterology.
[17] J. Cecka. The OPTN/UNOS Renal Transplant Registry 2003. , 2003, Clinical transplants.
[18] E. Marbán,et al. Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy Specimens , 2007, Circulation.
[19] J. Bonventre,et al. Repair of injured proximal tubule does not involve specialized progenitors , 2011, Proceedings of the National Academy of Sciences.
[20] D. Cyranoski. Stem cells cruise to clinic , 2013, Nature.
[21] R. Lund,et al. Non-Invasive Stem Cell Therapy in a Rat Model for Retinal Degeneration and Vascular Pathology , 2010, PloS one.
[22] G. Pless. Bioartificial liver support systems. , 2010, Methods in molecular biology.
[23] Lyndon da Cruz,et al. Stem cells in retinal regeneration: past, present and future , 2013, Development.
[24] M. Freedman,et al. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases , 2011, The Lancet Neurology.
[25] Patrick W Serruys,et al. First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. , 2012, Journal of the American College of Cardiology.
[26] C. Pino,et al. Stem cell technology for the treatment of acute and chronic renal failure. , 2010, Translational research : the journal of laboratory and clinical medicine.
[27] Weng Tao,et al. Two-year intraocular delivery of ciliary neurotrophic factor by encapsulated cell technology implants in patients with chronic retinal degenerative diseases. , 2012, Investigative ophthalmology & visual science.
[28] A. Testori,et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study , 2009, The Lancet Neurology.
[29] N. Wright,et al. Bone marrow stem cell-mediated regeneration in IBD: where do we go from here? , 2007, Gastroenterology.
[30] F. Ovalle. C-Peptide Levels and Insulin Independence Following Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus , 2009 .
[31] S. Ichinose,et al. Synovial Stem Cells Are Regionally Specified According to Local Microenvironments After Implantation for Cartilage Regeneration , 2007, Stem cells.
[32] G. Prescott,et al. Acute renal failure requiring renal replacement therapy: incidence and outcome. , 2002, QJM : monthly journal of the Association of Physicians.
[33] Yi Wei Zhang,et al. Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors. , 2006, Stem cells and development.
[34] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[35] Cecka Jm. The OPTN/UNOS Renal Transplant Registry 2003. , 2003 .
[36] A. Ho,et al. Stem cell therapy for retinal disease , 2012, Current opinion in ophthalmology.
[37] Jae Hoon Kim,et al. Ocular surface reconstruction with autologous nasal mucosa in cicatricial ocular surface disease. , 2010, American journal of ophthalmology.
[38] G. Camussi,et al. Isolation of renal progenitor cells from adult human kidney. , 2005, The American journal of pathology.
[39] Elias A. Rivera,et al. Functional Evaluation of Primary Renal Cell/Biomaterial Neo-Kidney Augment Prototypes for Renal Tissue Engineering , 2011, Cell transplantation.
[40] D. Hart,et al. The influence of skeletal maturity on allogenic synovial mesenchymal stem cell-based repair of cartilage in a large animal model. , 2010, Biomaterials.
[41] T. Wheeler,et al. A modified procedure for simultaneous extraction and subsequent assay of calcium-dependent and lysosomal protease systems from a skeletal muscle biopsy. , 1991, Journal of animal science.
[42] O. Isacson,et al. Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid , 2010, Molecular and Cellular Neuroscience.
[43] T. Liman,et al. New Vessels after Stroke: Postischemic Neovascularization and Regeneration , 2012, Cerebrovascular Diseases.
[44] M. Ochi,et al. Articular cartilage repair using an intra‐articular magnet and synovium‐derived cells , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[45] D. Clegg,et al. Pluripotent human stem cells for the treatment of retinal disease , 2012, Journal of cellular physiology.
[46] A. Vercelli,et al. Transplantation of mesenchymal stem cells in ALS. , 2012, Progress in brain research.
[47] J. Nolta,et al. Mesenchymal stem cells for the treatment of neurodegenerative disease. , 2010, Regenerative medicine.
[48] David M Gamm,et al. Optic Vesicle‐like Structures Derived from Human Pluripotent Stem Cells Facilitate a Customized Approach to Retinal Disease Treatment , 2011, Stem cells.
[49] A. Andoh,et al. Intestinal subepithelial myofibroblasts in inflammatory bowel diseases , 2002, Journal of Gastroenterology.
[50] P. Dharmasaroja. Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke , 2009, Journal of Clinical Neuroscience.
[51] H. Atkins,et al. Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Top 10 Lessons Learned , 2012, Neurotherapeutics.
[52] S. Giannini,et al. Cartilage repair evolution in post-traumatic osteochondral lesions of the talus: from open field autologous chondrocyte to bone-marrow-derived cells transplantation. , 2010, Injury.
[53] Ron Edgar,et al. LifeMap Discovery™: The Embryonic Development, Stem Cells, and Regenerative Medicine Research Portal , 2013, PloS one.
[54] A. Schäffler,et al. Concise Review: Adipose Tissue‐Derived Stromal Cells—Basic and Clinical Implications for Novel Cell‐Based Therapies , 2007, Stem cells.
[55] Yanfang Chen,et al. Endothelial Progenitor Cells: Therapeutic Perspective for Ischemic Stroke , 2013, CNS neuroscience & therapeutics.
[56] D. Prockop,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.
[57] S. Strom,et al. Hepatocyte transplantation for inherited metabolic diseases of the liver , 2012, Journal of internal medicine.
[58] Erik Jørgensen,et al. Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design. , 2012, Regenerative medicine.
[59] Douglas Losordo,et al. Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. , 2013, Circulation research.
[60] A. Haverich,et al. Stem cell therapy for the treatment of acute myocardial infarction and chronic ischemic heart disease. , 2013, Current pharmaceutical biotechnology.
[61] A. Cope,et al. Cell therapy for autoimmune diseases , 2007, Arthritis research & therapy.
[62] Y. S. Kim,et al. Pseudoislet of hybrid cellular spheroids from commercial cell lines. , 2013, Transplantation proceedings.
[63] M. Nagarkatti,et al. Stem cells as potential therapeutic targets for inflammatory bowel disease. , 2010, Frontiers in bioscience.
[64] Benjamin S. Freedman,et al. Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. , 2014, Journal of the American Society of Nephrology : JASN.
[65] A. Messias,et al. INTRAVITREAL INJECTION OF AUTOLOGOUS BONE MARROW–DERIVED MONONUCLEAR CELLS FOR HEREDITARY RETINAL DYSTROPHY: A Phase I Trial , 2011, Retina.
[66] C. Thanos,et al. Encapsulated porcine islet transplantation: an evolving therapy for the treatment of type I diabetes. , 2009, Expert opinion on biological therapy.
[67] 本間 龍介. Induction of epithelial progenitors in vitro from mouse embryonic stem cells and application for reconstruction of damaged cornea in mice , 2005 .
[68] J. Farr,et al. A Prospective Study of Autologous Chondrocyte Implantation in Patients with Failed Prior Treatment for Articular Cartilage Defect of the Knee , 2009, The American journal of sports medicine.
[69] S. E. Jacobsen,et al. Potential risks of bone marrow cell transplantation into infarcted hearts. , 2007, Blood.
[70] P. Romagnani,et al. Stem-cell approaches for kidney repair: choosing the right cells. , 2008, Trends in molecular medicine.
[71] R. Nishinakamura,et al. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. , 2014, Cell stem cell.
[72] Jeff W M Bulte,et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. , 2010, Archives of neurology.
[73] M. Chopp,et al. Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery , 2002, Neurology.
[74] A. Björklund,et al. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease , 2013, The Lancet Neurology.
[75] Dong-Wook Kim,et al. Efficient derivation of functional dopaminergic neurons from human embryonic stem cells on a large scale , 2008, Nature Protocols.
[76] Wei Wang,et al. Recovery of neurological functions in non-human primate model of Parkinson's disease by transplantation of encapsulated neonatal porcine choroid plexus cells. , 2013, Journal of Parkinson's disease.
[77] F. Moll,et al. Autologous Bone Marrow–Derived Cell Therapy in Patients With Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Clinical Trials , 2013, Annals of surgery.
[78] D. Slovut,et al. Critical limb ischemia: medical and surgical management , 2008, Vascular medicine.
[79] R. Malekzadeh,et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. , 2007, Archives of Iranian medicine.
[80] D. Clegg,et al. Protective Effects of Human iPS-Derived Retinal Pigment Epithelium Cell Transplantation in the Retinal Dystrophic Rat , 2009, PloS one.
[81] B. Nordlinger,et al. Semiautomatic Macroencapsulation of Fresh or Cryopreserved Porcine Hepatocytes Maintain Their Ability for Treatment of Acute Liver Failure , 2001, Cell transplantation.
[82] Susanna S. Park,et al. Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury. , 2012, Investigative ophthalmology & visual science.
[83] E. Ryan,et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.
[84] S. Yamanaka,et al. Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. , 2010, The Journal of clinical investigation.
[85] J. Sinden,et al. The Neural Stem Cell Line CTX0E03 Promotes Behavioral Recovery and Endogenous Neurogenesis After Experimental Stroke in a Dose-Dependent Fashion , 2009, Neurorehabilitation and neural repair.
[86] D. Baiu,et al. Potential Pathways to Restore β-Cell Mass: Pluripotent Stem Cells, Reprogramming, and Endogenous Regeneration , 2011, Current diabetes reports.
[87] D. Melton,et al. How to make a functional β-cell , 2013, Development.
[88] M. Fontaine,et al. Harnessing the Immunomodulatory and Tissue Repair Properties of Mesenchymal Stem Cells to Restore β Cell Function , 2012, Current Diabetes Reports.
[89] M. Chopp,et al. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat , 2003, Journal of neuroscience research.
[90] Y. Cohen,et al. Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases. , 2009, The Israel Medical Association journal : IMAJ.
[91] M. Carini,et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. , 2006, Journal of the American Society of Nephrology : JASN.
[92] I. Weissman,et al. Stem Cells Units of Development, Units of Regeneration, and Units in Evolution , 2000, Cell.
[93] Ana Paula Pêgo,et al. Regenerative medicine for the treatment of spinal cord injury: more than just promises? , 2012, Journal of cellular and molecular medicine.
[94] D. Howells,et al. Stem Cell Transplantation in Traumatic Spinal Cord Injury: A Systematic Review and Meta-Analysis of Animal Studies , 2013, PLoS biology.
[95] R. Siqueira. Stem cell therapy for retinal diseases: update , 2011, Stem Cell Research & Therapy.
[96] S. Mousa,et al. Treatment options for diabetes: potential role of stem cells. , 2012, Diabetes Research and Clinical Practice.
[97] S. Sadiq,et al. Characterization of Autologous Mesenchymal Stem Cell‐Derived Neural Progenitors as a Feasible Source of Stem Cells for Central Nervous System Applications in Multiple Sclerosis , 2012, Stem cells translational medicine.
[98] Vesna Sossi,et al. A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease , 2003, Annals of neurology.
[99] S. Efrat. Beta-cell replacement for insulin-dependent diabetes mellitus. , 2008, Advanced drug delivery reviews.
[100] Y. Son,et al. Schwann cells differentiated from spheroid-forming cells of rat subcutaneous fat tissue myelinate axons in the spinal cord injury , 2010, Experimental Neurology.
[101] E. Sokal,et al. From hepatocytes to stem and progenitor cells for liver regenerative medicine: advances and clinical perspectives , 2011, Cell proliferation.
[102] J. Karp,et al. Mesenchymal stem cell therapy: Two steps forward, one step back. , 2010, Trends in molecular medicine.
[103] Daniel Berman,et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial , 2012, The Lancet.
[104] H. Blau,et al. The Evolving Concept of a Stem Cell Entity or Function? , 2001, Cell.
[105] Thomas M van Gulik,et al. Clinical Application of Bioartificial Liver Support Systems , 2004, Annals of surgery.
[106] D. Schatz,et al. Update on global intervention studies in type 1 diabetes. , 2012, Endocrinology and metabolism clinics of North America.
[107] S. Terai,et al. Improved Liver Function in Patients with Liver Cirrhosis After Autologous Bone Marrow Cell Infusion Therapy , 2006, Stem cells.
[108] A. Vercelli,et al. Stem cells in amyotrophic lateral sclerosis: state of the art , 2009, Expert opinion on biological therapy.
[109] J. A. Gomes,et al. Transplantation of Conjunctival Epithelial Cells Cultivated Ex Vivo in Patients With Total Limbal Stem Cell Deficiency , 2013, Cornea.
[110] J. Kesslak,et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease , 2001 .
[111] S. Koelling,et al. Stem cell therapy for cartilage regeneration in osteoarthritis , 2009, Expert opinion on biological therapy.
[112] A. Hardikar,et al. New sources of beta-cells for treating diabetes. , 2009, The Journal of endocrinology.
[113] J. Daniels,et al. Concise Review: Limbal Epithelial Stem Cell Therapy: Controversies and Challenges , 2011, Stem cells.
[114] R Tubo,et al. Alternative delivery of keratinocytes using a polyurethane membrane and the implications for its use in the treatment of full-thickness burn injury. , 1998, Burns : journal of the International Society for Burn Injuries.
[115] S. Sedrakyan,et al. Stem Cells as a Therapeutic Approach to Chronic Kidney Diseases , 2012, Current Urology Reports.
[116] W. Marston,et al. Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[117] B. Strauer,et al. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. , 2011, Journal of the American College of Cardiology.
[118] Richard S. J. Frackowiak,et al. Transplantation of fetal dopamine neurons in Parkinson's disease: One‐year clinical and neurophysiological observations in two patients with putaminal implants , 1992, Annals of neurology.
[119] R. Franzen,et al. Concise Review: Spinal Cord Injuries: How Could Adult Mesenchymal and Neural Crest Stem Cells Take Up the Challenge? , 2014, Stem cells.
[120] David J. Williams,et al. Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies. , 2013, British medical bulletin.
[121] D. Emerich,et al. Choroid plexus transplants in the treatment of brain diseases , 2006, Xenotransplantation.
[122] T. Vigo,et al. The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms , 2012, Stem Cell Research & Therapy.
[123] J. Thomson,et al. Embryonic stem cell lines derived from human blastocysts. , 1998, Science.
[124] Nobuko Uchida,et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[125] Roland Martin,et al. Hematopoietic stem cell transplantation for multiple sclerosis: current status and future challenges. , 2003, Current opinion in neurology.
[126] S. Dimmeler,et al. Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.
[127] Marcus F Stoddard,et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial , 2011, The Lancet.
[128] B. Genser,et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. , 2007, World journal of gastroenterology.
[129] Shahid A. Khan,et al. Autologous Infusion of Expanded Mobilized Adult Bone Marrow-Derived CD34+ Cells Into Patients With Alcoholic Liver Cirrhosis , 2008, The American Journal of Gastroenterology.
[130] B. Prabhakar,et al. Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells , 2012, BMC Medicine.
[131] A. Testori,et al. Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia , 2010, Bone Marrow Transplantation.
[132] S. Rivest,et al. Immune Mechanisms Underlying the Beneficial Effects of Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis , 2011, Neurotherapeutics.
[133] J. Song,et al. Innovation in the Treatment of Uremia: Proceedings from the Cleveland Clinic Workshop: Renal Cell Therapy and Beyond , 2009, Seminars in dialysis.
[134] H. Atkins,et al. The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group , 2010, Multiple sclerosis.
[135] R. Tuan,et al. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy , 2004, Journal of cellular and molecular medicine.
[136] H. Haider,et al. MyoCell, a cell-based, autologous skeletal myoblast therapy for the treatment of cardiovascular diseases. , 2008, Current opinion in molecular therapeutics.
[137] Zheng Li,et al. Generation, characterization and potential therapeutic applications of mature and functional hepatocytes from stem cells , 2013, Journal of cellular physiology.
[138] S. Schwartz,et al. Embryonic stem cell trials for macular degeneration: a preliminary report , 2012, The Lancet.
[139] F. Timmermans,et al. Endothelial progenitor cells: identity defined? , 2008, Journal of cellular and molecular medicine.
[140] S. Cohan,et al. A randomized clinical trial of autologous T-cell therapy in multiple sclerosis: subset analysis and implications for trial design , 2012, Multiple sclerosis.
[141] O. Lee,et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. , 2008, Gastroenterology.
[142] Y. Tai,et al. A Novel Approach for Subretinal Implantation of Ultrathin Substrates Containing Stem Cell-Derived Retinal Pigment Epithelium Monolayer , 2012, Ophthalmic Research.
[143] Lei Jin,et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients , 2012, Journal of gastroenterology and hepatology.
[144] S. Shi,et al. Mesenchymal Stem Cells Derived from Human Gingiva Are Capable of Immunomodulatory Functions and Ameliorate Inflammation-Related Tissue Destruction in Experimental Colitis1 , 2009, The Journal of Immunology.
[145] Min-Jeong Seo,et al. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. , 2005, Biochemical and biophysical research communications.
[146] B. Vrtovec,et al. Stem cell therapy in patients with heart failure. , 2013, Methodist DeBakey cardiovascular journal.
[147] Weng Tao,et al. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[148] Roger M. Ilagan,et al. Tubular cell-enriched subpopulation of primary renal cells improves survival and augments kidney function in rodent model of chronic kidney disease. , 2010, American journal of physiology. Renal physiology.
[149] D. Clegg,et al. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins , 2013, Journal of tissue engineering and regenerative medicine.
[150] D. Schuppan,et al. Evolving therapies for liver fibrosis. , 2013, The Journal of clinical investigation.
[151] Rafael Beyar,et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. , 2007, Journal of the American College of Cardiology.
[152] A. Keating,et al. Concise review: Bone marrow autotransplants for liver disease? , 2013, Stem cells.
[153] L. Peng,et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short‐term and long‐term outcomes , 2011, Hepatology.
[154] I. Weissman,et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[155] S. Weiss,et al. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. , 1992, Science.
[156] J. Tumlin,et al. Cell-Based Strategies for the Treatment of Kidney Dysfunction: A Review , 2012, Blood Purification.
[157] Yali Kang,et al. A long-term observation of olfactory ensheathing cells transplantation to repair white matter and functional recovery in a focal ischemia model in rat , 2010, Brain Research.
[158] A. Glavaski-Joksimovic,et al. Mesenchymal stem cells and neuroregeneration in Parkinson's disease , 2013, Experimental Neurology.
[159] J. Bulte,et al. Stem cell therapy for myelin diseases. , 2005, Current drug targets.
[160] E. Stanley,et al. Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney , 2013, Nature Cell Biology.
[161] Robert Lanza,et al. EMBRYONIC STEM CELLS / INDUCED PLURIPOTENT STEM CELLS Long-Term Safety and Function of RPE from Human Embryonic Stem Cells in Preclinical Models of Macular Degeneration , 2009 .
[162] Yi Li,et al. Intravenous Administration of Human Bone Marrow Stromal Cells Induces Angiogenesis in the Ischemic Boundary Zone After Stroke in Rats , 2003, Circulation research.
[163] J. Glass,et al. Lumbar Intraspinal Injection of Neural Stem Cells in Patients with Amyotrophic Lateral Sclerosis: Results of a Phase I Trial in 12 Patients , 2012, Stem cells.
[164] Mohamed Hegazy,et al. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells , 2011, European journal of gastroenterology & hepatology.
[165] Myeong-Jin Kim,et al. Autologous Bone Marrow Infusion Activates the Progenitor Cell Compartment in Patients with Advanced Liver Cirrhosis , 2010, Cell transplantation.
[166] R. Galli,et al. Neural Stem Cells: An Overview , 2003, Circulation research.
[167] C. Choong,et al. Application of liver stem cells for cell therapy. , 2007, Seminars in cell & developmental biology.
[168] Zhifeng Xiao,et al. Reconstruction of Chemically Burned Rat Corneal Surface by Bone Marrow–Derived Human Mesenchymal Stem Cells , 2006, Stem cells.
[169] Glenn J Jaffe,et al. Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa. , 2013, American journal of ophthalmology.
[170] S. Nyberg,et al. Cell therapies for liver diseases , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[171] S. Fichtlscherer,et al. A Pilot Trial to Assess Potential Effects of Selective Intracoronary Bone Marrow–Derived ProgenitorCell Infusion in Patients With Nonischemic Dilated Cardiomyopathy: Final 1-Year Results of the Transplantation of Progenitor Cellsand Functional Regeneration Enhancement Pilot Trial in PatientsWith Non , 2009, Circulation. Heart failure.
[172] Sender Herschorn,et al. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study. , 2013, The Journal of urology.
[173] G. Keller,et al. Generation of beta cells from human pluripotent stem cells: Potential for regenerative medicine. , 2012, Seminars in cell & developmental biology.
[174] William Wijns,et al. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. , 2013, Journal of the American College of Cardiology.
[175] F. Tögel,et al. Kidney protection and regeneration following acute injury: progress through stem cell therapy. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[176] J. Lebkowski,et al. Immunological properties of human embryonic stem cell-derived oligodendrocyte progenitor cells , 2007, Journal of Neuroimmunology.
[177] R. Siqueira. Stem cell therapy in retinal diseases? , 2012, Revista brasileira de hematologia e hemoterapia.
[178] Brian J Cummings,et al. Human Neural Stem Cells Differentiate and Promote Locomotor Recovery in an Early Chronic Spinal coRd Injury NOD-scid Mouse Model , 2010, PloS one.
[179] I. Amit,et al. Derivation of novel human ground state naive pluripotent stem cells , 2013, Nature.
[180] R. Oldershaw,et al. Cell sources for the regeneration of articular cartilage: the past, the horizon and the future , 2012, International journal of experimental pathology.
[181] S. Thorgeirsson,et al. Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver , 2006, Hepatology.
[182] V. Koliatsos,et al. Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: Differentiation and structural integration into the segmental motor circuitry , 2009, The Journal of comparative neurology.
[183] K. Shimada,et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial , 2002, The Lancet.
[184] R. Dempsey,et al. The potential of neural stem cells to repair stroke-induced brain damage , 2009, Acta Neuropathologica.
[185] K. Tarte,et al. Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal. , 2013, Cytotherapy.
[186] Sanjiv S. Gambhir,et al. Transcriptional and Functional Profiling of Human Embryonic Stem Cell-Derived Cardiomyocytes , 2008, PloS one.